Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic.
Claudio MarascaRuggiero AngeloG FontanellaMaria FerrilloG FabbrociniAlessia VillaniPublished in: Clinical and experimental dermatology (2020)